Integra Lifesciences Holdings (IART) Tax Provisions (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Tax Provisions data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 146.55% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$40.1 million (down 184.5% YoY), and the FY2025 full-year result was -$47.0 million, down 316.43% from the prior year.
• Tax Provisions slipped to $2.2 million in Q1 2026, from $6.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $11.3 million in Q4 2022 to a low of -$46.9 million in Q2 2025.
• A 5-year average of -$555352.9 and a median of $2.2 million in 2026 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions slumped 1584.48% in 2025 and jumped 146.55% in 2026, its largest moves.
• Tracing IART's Tax Provisions over 5 years: stood at $11.3 million in 2022, then dropped by 19.87% to $9.0 million in 2023, then tumbled by 65.58% to $3.1 million in 2024, then surged by 93.63% to $6.0 million in 2025, then tumbled by 63.29% to $2.2 million in 2026.
• Business Quant data shows IART's Tax Provisions at $2.2 million in Q1 2026, $6.0 million in Q4 2025, and -$1.4 million in Q3 2025.